Antidepressant Medications

DRUG3 trials

Sponsors

Indiana University, Mehmet Kemal Arikan

Conditions

Cardiovascular DiseasesCoronary Artery DiseaseDepressionDepressive SymptomsDysthymic DisorderHealthyHeart DiseasesInsulin Resistance

Phase 2

eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients

CompletedNCT02458690

Indiana UniversityCardiovascular Diseases, Coronary Artery Disease, Depression +5

Start: 2015-07-31End: 2021-03-31Updated: 2023-10-19

eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk

CompletedNCT04437485

Indiana UniversityDepression, Depressive Symptoms, Dysthymic Disorder +4

Start: 2020-10-14End: 2022-08-29Updated: 2023-11-02

Unknown Phase

Neurobiological and Genomic Predictors of Relapse in Depression

RecruitingNCT07328373

Mehmet Kemal ArikanHealthy, Major Depressive Disorder (MDD)

Start: 2025-01-01End: 2027-02-01Target: 204Updated: 2026-01-09

Related Papers

Longer-term effects of modernized collaborative care for depression on multiple mental health factors (eIMPACT): A randomized controlled trial.

2025-09-08

Effect of depression treatment on subjective sleep components among primary care patients: Data from the eIMPACT trial

Journal of Mood and Anxiety Disorders2025-06-03

Effect of depression treatment on health behaviors and cardiovascular risk factors in primary care patients with depression and elevated cardiovascular risk: data from the eIMPACT trial

Psychological Medicine2024-09-013 citations

Effect of modernized collaborative care for depression on brain-derived neurotrophic factor (BDNF) and depressive symptom clusters: Data from the eIMPACT trial.

2023-10-301 citations

Effect of modernized collaborative care for depression on depressive symptoms and cardiovascular disease risk biomarkers: eIMPACT randomized controlled trial.

2023-05-1815 citations